Role of HIV Drug Resistance Testing in Antiretroviral Drug Development
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 31, 2007
February 1, 2021
b63afac3-86d1-45b1-bee0-b25944c92926
Related Documents
Orally Inhaled and Intranasal Corticosteroids: Evaluation of the Effects on Growth in Children
Guidance DocumentMarch 6, 2007Center for Drug Evaluation and Research
Nonclinical Safety Evaluation of Pediatric Drug Products
Guidance DocumentFebruary 15, 2006Center for Drug Evaluation and Research
User Fee Waivers for FDC and Co-Packaged HIV Drugs for PEPFAR
Guidance DocumentFebruary 8, 2007Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.